Posted on April 7, 2021 at 3:15am
0 Likes
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.
Owing to various reasons, the demand for cell therapies is anticipated to increase over the…
Continue
Comment Wall
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation